HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mortality surveillance in a large chemical company: the Union Carbide Corporation experience, 1974-1983.

Abstract
The mortality experience of 88,000 Union Carbide Corporation employees from 1974 to 1983 is presented using a population-based surveillance system. The study included many long-term employees, with most deaths contributed by those retired or terminated. The total population exhibited 30% lower mortality overall and 10% lower cancer mortality, as compared with the general U.S. population. Excesses of benign neoplasms and malignant melanoma of the skin were observed in both hourly and salaried males. Mortality rates for lymphosarcoma and reticulosarcoma were significantly elevated due to higher rates among hourly male employees and a cluster in one location. This same location also exhibited an excess of liver cancer associated with vinyl chloride operations. There were no other significant excesses in the hourly male workers and fewer deaths than expected due to brain cancer, respiratory cancer, and nonmalignant respiratory diseases. Salaried, and particularly hourly, women experienced favorable mortality, although for the women, time since hire was relatively short. Location-specific findings were similar to what had been observed in the company's previously conducted cohort studies. Future value lies in the development of a database that will have greater power to address possible effects of past exposures and outcomes related to more recent lower level exposures.
AuthorsM J Teta, A R Schnatter, M G Ott, S Pell
JournalAmerican journal of industrial medicine (Am J Ind Med) Vol. 17 Issue 4 Pg. 435-47 ( 1990) ISSN: 0271-3586 [Print] United States
PMID2183596 (Publication Type: Journal Article)
Topics
  • Cause of Death
  • Chemical Industry
  • Death Certificates
  • Humans
  • Lymphoma, Large B-Cell, Diffuse (mortality)
  • Lymphoma, Non-Hodgkin (mortality)
  • Male
  • Neoplasms (chemically induced, mortality)
  • Occupational Diseases (mortality)
  • Population Surveillance
  • Risk Factors
  • United States (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: